What is Xtant Medical Holdings's market cap?

Xtant Medical Holdings (XTNT) has a market capitalization of $61.7M and trades on AMEX.

What is Xtant Medical Holdings's revenue and profitability?

Xtant Medical Holdings generated $121.9M in trailing twelve-month revenue with net income of $1.8M, representing a net margin of 1.5%. Gross margin stands at 62.3%, with free cash flow of $7.8M. These figures are based on the Q1 2026 filing.

Who are Xtant Medical Holdings's competitors?

Xtant Medical Holdings's key competitors include Orthofix Medical Inc., Globus Medical, Inc., Alphatec Holdings, Inc., and others. These companies compete in similar markets and product categories.

Who does Xtant Medical Holdings partner with?

Xtant Medical Holdings's notable partners include Vizient, Premier, HealthTrust Purchasing Group, and others.

What subsidiaries does Xtant Medical Holdings have?

Xtant Medical Holdings's subsidiaries include X-spine Systems, Inc., Xtant Medical, Inc..

Where is Xtant Medical Holdings headquartered?

Xtant Medical Holdings is headquartered in United States of America and employs approximately 215 people. It has been publicly traded since 2007.

Xtant Medical Holdings

XTNT

Xtant Medical Holdings, Inc. is a global medical technology company that designs, develops, and commercializes a comprehensive portfolio of orthobiologics and spinal implant fixation systems.

Market cap

$61.7M-25.9%

Revenue$121.9M-0.3%

Net income$1.8M+115%

Free cash flow$7.8M+183%

EPS (diluted)$0.01+111%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 13, 2026

Revenue$20.9MBeat by $719.7K EPS-$0.02Miss by $0.01

Read the full report

Next report

Aug 12, 2026 (In 2 weeks)

Revenue estimate$24.9M

EPS estimate-$0.02

Financials

Q1 2026

Income statement

See full

Revenue$20.9M-36.5%

Gross profit$12.0M-40.9%

Operating income-$2.9M-375%

Net income-$3.1M-5,426%

EPS (diluted)-$0.02—

Balance sheet

See full

Cash & equivalents$12.2M+124%

Total debt$15.0M-34.9%

Total equity$48.6M+10.8%

Total assets$78.0M-18.6%

Cash flow

See full

Operating cash flow-$2.1M-265%

CapEx$194.0K-83.7%

Free cash flow-$2.3M-2,753%

Valuation & ratios

Valuation

See full

Market cap$61.7M-25.9%

Enterprise value$64.54M-39.0%

P/E33.8×—

P/S0.5×-0.2×

Profitability

See full

Gross margin62.3%+4.2pp

Net margin1.5%+0.8pp

FCF margin6.4%+4.1pp

Returns & leverage

See full

Return on equity3.9%+2.1pp

Debt / equity0.3×-0.2×

Current ratio3.3×+1.0×

Segments

By product

See full

Orthobiologics$15.6M-13.6%

Spinal Implant$5.3M-52.9%

Competitors

By market cap

Stryker$129.09B-15.7%

Zimmer Biomet Holdings$17.8B-6.2%

Globus Medical$10.6B+44.5%

Alphatec Holdings$1.3B-18.5%

Bioventus$843.5M+94.7%

SI-BONE, Inc.$756.2M+0.8%

Orthofix Medical Inc.$481.0M+7.7%

Xtant Medical Holdings$61.7M-29.7%

By revenue growth

Globus Medical+23.5%

Alphatec Holdings+22.6%

SI-BONE, Inc.+16.8%

Zimmer Biomet Holdings+9.2%

Stryker+8.8%

Orthofix Medical Inc.+2.6%

Bioventus+1.5%

Xtant Medical Holdings-0.3%

By net margin

Globus Medical18.92%+11.5pp

Stryker13.21%+0.9pp

Zimmer Biomet Holdings9.05%-2.8pp

Bioventus4.94%+10.9pp

Xtant Medical Holdings1.5%+11.3pp

Orthofix Medical Inc.-7.27%+10.5pp

SI-BONE, Inc.-8.1%+6.9pp

Alphatec Holdings-15.93%+9.8pp

Profile

Xtant Medical Holdings, Inc. is a global medical technology company that designs, develops, and commercializes a comprehensive portfolio of orthobiologics and spinal implant fixation systems. The company's solutions facilitate spinal fusion in complex spine, deformity, and degenerative procedures, while its biologics are also utilized in trauma, sports medicine, and wound care. Xtant's core value proposition lies in providing a dual-portfolio approach that combines human-derived tissue products with advanced hardware systems to improve surgical outcomes.

Competitive position

Xtant maintains a competitive position by offering a integrated portfolio of both hardware and biologics, supported by a large network of over 670 independent distributors and significant intellectual property.

GeographiesUnited States, Europe, Canada, Mexico, South America

Customer segmentsHospitals, Integrated Delivery Networks, Group Purchasing Organizations

Business modelManufacturing, Direct Sales, Licensing

SuppliersTissue recovery agencies, Bovine collagen suppliers, Titanium and PEEK material suppliers, Contract manufacturers

CustomersIntegrated Delivery Networks (IDNs), Group Purchasing Organizations (GPOs), Hospitals, Surgical centers

CountryUnited States of America

Listed2007

Employees215.0

CEOSean E. Browne

SectorHealthcare

IndustryMedical - Devices

Websitextantmedical.com

FilingsSEC EDGAR

Ask your AI about Xtant Medical Holdings.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xtant Medical Holdings's market cap?: Xtant Medical Holdings (XTNT) has a market capitalization of $61.7M and trades on AMEX.
What is Xtant Medical Holdings's revenue and profitability?: Xtant Medical Holdings generated $121.9M in trailing twelve-month revenue with net income of $1.8M, representing a net margin of 1.5%. Gross margin stands at 62.3%, with free cash flow of $7.8M. These figures are based on the Q1 2026 filing.
Who are Xtant Medical Holdings's competitors?: Xtant Medical Holdings's key competitors include Orthofix Medical Inc., Globus Medical, Inc., Alphatec Holdings, Inc., and others. These companies compete in similar markets and product categories.
Who does Xtant Medical Holdings partner with?: Xtant Medical Holdings's notable partners include Vizient, Premier, HealthTrust Purchasing Group, and others.
What subsidiaries does Xtant Medical Holdings have?: Xtant Medical Holdings's subsidiaries include X-spine Systems, Inc., Xtant Medical, Inc..
Where is Xtant Medical Holdings headquartered?: Xtant Medical Holdings is headquartered in United States of America and employs approximately 215 people. It has been publicly traded since 2007.